CARsgen Therapeutics
CARsgen Presents First Clinical Data on Its In Vivo CAR-T Product Candidate CT1182
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces the clinical…

